logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
A

Ahmet Bılıcı

i̇stanbul medipol university

26H指数
375论文数
3.8K被引数
收录论文 55
发表时间
logo
Prognostic Significance and Clinical Implications of the New FIGO 2023 Staging System in Patients with Endometrial Cancer新FIGO 2023分期系统在子宫内膜癌患者中的预后意义和临床意义
errJournal of Clinical Medicine
IF2.9
err2026-08-16
err0
errOAAI
errHakan Özçelik; Nazan Demir; Melisa Eryaşar; Oğuz Çelebi; Erdem Sünger; Burçin Çakan Demirel; Jamshid Hamdard; Özgür Açıkgöz; Burak Giray; Doğan Vatansever; İsa Aykut Özdemir; Volkan Ülker; Çağatay Taşkıran; Fatih Selcukbiricik; Ahmet Bilici
err分享
err收藏
Efficacy and Tolerability of Pazopanib in Elderly Patients with Advanced Soft Tissue Sarcoma: A Multicentre Real-World Study from Turkey帕唑帕尼在老年晚期软组织肉瘤患者中的疗效和耐受性：来自土耳其的多中心真实世界研究
errJournal of Clinical Medicine
IF2.9
err2026-06-23
err0
errOAAI
errMehmet Mutlu Kidi; Harun Muğlu; Mustafa Karaağaç; Sinan Koca; Oguz Kara; Ahmet Bilici; Ertugrul Bayram
err分享
err收藏
Real-World Outcomes and Progression Patterns with First-Line Osimertinib in Patients with Advanced EGFR-Mutant Non-Small Cell Lung Cancer: A Nationwide Turkish Oncology Group Study真实世界结局与进展模式：土耳其国家肿瘤学组研究——一线奥希替尼治疗晚期EGFR突变非小细胞肺癌患者的疗效
errCancers
IF4.4
err2026-06-18
err0
errOAAI
errBahadır Köylü; Özde Melisa Celayir; Harun Muğlu; Orçun Can; Fatma Şen; Bala Başak Öven; Umut Demirci; Teoman Şakalar; Serdar Karakaya; Özlem Er; Ömer Burak Ekinci; Abdullah Sakin; Hasibe Bilge Gür; Yağmur Karaman; Duygu Ercan Uzundal; Esra Aşık; Kezban Nur Pilancı; Nilüfer Avcı; Pınar Gürsoy; Muhammet Ali Kaplan; Serkan Menekşe; Engin Kut; Erkan Arpacı; Hakan Kosku; Selami Bayram; Taha Koray Şahin; Emine Türkmen; Abdurrahman Aykut; Yeşim Ağyol; Ahmet Özveren; Elif Şahin; Öztürk Ateş; Gamze Serin Özel; Cevat İlteriş Kıkılı; Fatih Kemik; Başak Oyan; Taner Korkmaz; Osman Gökhan Demir; Deniz Tural; Şeyda Gündüz; Şahin Laçin; Nazan Demir; Didem Tunalı; Ahmet Bilici; Ömer Fatih Ölmez; İlhan Hacıbekiroğlu; Erdem Çubukçu; Ozan Yazıcı; Atila Yıldırım; Burak Bilgin; Mehmet Ali Nahit Şendur; Ali Murat Tatlı; Mustafa Özdoğan; Burak Yasin Aktaş; Metin Kanıtez; Bülent Karabulut; Ferhat Ekinci; Ertuğrul Bayram; Gamze Gököz Doğu; Saadettin Kılıçkap; Perran Fulden Yumuk; Nil Molinas Mandel; Fatih Selçukbiricik
err分享
err收藏
A Novel Biological Index for Predicting Neoadjuvant Treatment Response in HER2-Positive Breast Cancer: The Tumor-Immune-Proliferation-Inflammation (TIPI) Score一种用于预测HER2阳性乳腺癌新辅助治疗反应的新型生物指标：肿瘤-免疫-增殖-炎症（TIPI）评分
errJournal of Clinical Medicine
IF2.9
err2026-04-19
err0
errOAAI
errErdem Sünger; Harun Muğlu; Mehmet Haluk Yücel; Ebru Engin Delipoyraz; Maral Martin Mıldanoğlu; Hakan Özçelik; Sena Fidan; Cihat Terzioğlu; Burçin Çakan Demirel; Jamshid Hamdard; Yasin Kutlu; Özgür Açıkgöz; Aslı Çakır; Mesut Şeker; Ahmet Bilici
err分享
err收藏
Real-World Outcomes of Neoadjuvant Dual Blockade in HER2-Positive Breast Cancer: The Role of Tumor Biology and pCRHER2阳性乳腺癌新辅助双重抑制治疗的现实世界结果：肿瘤生物学与病理完全缓解的作用
errJournal of Clinical Medicine
IF2.9
err2026-04-17
err0
errOAAI
errAyberk Bayramgil; Mehmet Haluk Yücel; Ezgi Turkoglu; Ali Kaan Guren; Fatih Kemik; Bedirhan Ulufer; Burçin Çakan Demirel; Anil Yildiz; Omer Sacli; Eda Ercin; Nazım Can Demircan; Oguzcan Kinikoglu; Sahin Lacin; Ahmet Bilici; Yunus Emre Altintas; Melike Ozcelik
err分享
err收藏
Determinants of survival after neoadjuvant chemotherapy in resectable gastric cancer: adjuvant dose intensity, radiotherapy, and pathologic response可切除胃癌新辅助化疗后生存的影响因素：辅助剂量强度、放射治疗和病理反应
errExpert Review of Anticancer Therapy
IF2.8
err2026-04-13
err0
PREAI
errÖzgecan Dülgar Kaya; Ayberk Bayramgil; Ahmet Bilici; Erdem Sünger; Tuğba Kaya; Tuğba Başoğlu Tüylü; Tuba Baydaş; Sinan Koca; Yeşim Ağyol; Selver Işık; Burçin Çakan Demirel; Vedat Buğra Erol; Nilufer Bulut; Busra Niğdelioğlu; Melike Özçelik
err分享
err收藏
Survival Outcomes After irAE-Related Nivolumab Discontinuation in mNSCLC: A Multicenter StudyNivolumab治疗相关irAE导致停药后mNSCLC患者的生存结局：一项多中心研究
errJournal of Clinical Medicine
IF2.9
err2026-04-08
err0
errOAAI
errAysegul Merc Cetinkaya; Mehmet Haluk Yucel; Latif Karahan; Mustafa Ersoy; Ahmet Bilici; Mustafa Erman; Ali Murat Tatli; Sema Sezgin Goksu
err分享
err收藏
Combined Lung Immune Prognostic Index (LIPI)-Glasgow Prognostic Score (GPS) as a Prognostic Tool in Extensive-Stage Small-Cell Lung Cancer Treated with First-Line Chemo-Immunotherapy联合肺免疫预后指数（LIPI）-格拉斯哥预后评分（GPS）作为广泛期小细胞肺癌接受一线化疗免疫治疗的预后工具
errPharmaceuticals
IF4.8
err2026-04-07
err0
errOAAI
errMaral Martin Mıldanoğlu; Fatih Kemik; Melisa Eryaşar; Hakan Özçelik; Erdem Sünger; Mehmet Haluk Yücel; Ebru Engin Delipoyraz; Sena Fidan; Harun Muğlu; Burçin Çakan Demirel; Jamshid Hamdard; Yasin Kutlu; Özgür Açıkgöz; Fatih Selcukbiricik; Mesut Şeker; Ahmet Bilici
err分享
err收藏
Immunotherapy Versus Chemo-Immunotherapy as First-Line Treatment in Metastatic Non-Small Cell Lung Cancer Patients with PD-L1 TPS ≥ 50%: A Real-World Retrospective Study免疫治疗与化疗联合免疫治疗作为PD-L1 TPS ≥ 50%的转移性非小细胞肺癌患者的一线治疗：一项真实世界回顾性研究
errJournal of Clinical Medicine
IF2.9
err2026-04-06
err0
errOAAI
errMaral Martin Mildanoglu; Mehmet Haluk Yucel; Ebru Engin Delipoyraz; Erdem Sunger; Hakan Ozcelik; Sena Fidan; Cihat Terzioglu; Harun Muglu; Jamshid Hamdard; Burcin Cakan Demirel; Yasin Kutlu; Ozgur Acikgoz; Mesut Seker; Ahmet Bilici
err分享
err收藏
Prognostic Significance of Frailty in Liver Cirrhosis Patients: A Prospective Single-Center Study肝病患者虚弱症的预后意义：一项前瞻性单中心研究
errJournal of Clinical Medicine
IF2.9
err2026-03-04
err0
errOAAI
errMaral Martin Mıldanoğlu; Atilla Akpınar; Koray Koçhan; Ahmet Bilici; Elmas Biberci Keskin; Hakan Şentürk
err分享
err收藏
Relationship Between Mast Cell Population of Microenvironment and Prognosis in Colorectal Cancer微环境肥大细胞群体与结直肠癌预后的关系
errJournal of Clinical Medicine
IF2.9
err2026-03-03
err0
errOAAI
errNeşe Yeldir; Ebru Engin Delipoyraz; Aslı Çakır; Ahmet Bilici
err分享
err收藏
Association of Post-Neoadjuvant Chemotherapy MRI and 18F-FDG PET/CT Findings with Tumor Response and Prognosis in Breast Cancer新辅助化疗后MRI和18F-FDG PET/CT表现与乳腺癌肿瘤反应及预后的相关性
errDiagnostics
IF3.3
err2026-02-28
err0
errOAAI
errBurçin Çakan Demirel; Semra Taş; Ayberk Bayramgil; Anıl Yıldız; Şahin Bedir; Nigar Erkoç; Aynur Özen; Merve Tokoçin; Nida Sünnetçi Arıkan; Ali Muhammedoğlu; Yunus Emre Altıntaş; Ahmet Bilici
err分享
err收藏
Real-world effectiveness and safety of brigatinib in advanced ALK-positive NSCLC: a nationwide multicenter study by the Turkish Oncology Groupbrigatinib 在晚期ALK阳性NSCLC中的真实世界有效性与安全性：土耳其肿瘤学组进行的一项全国多中心研究
errClinical and Translational Oncology
IF2.5
err2026-02-11
err0
PREAI
errSalih Tunbekici; Hamit Bal; Oguzcan Kınıkoglu; Hayati Arvas; Harun Muglu; Ahmet Bilici; Mustafa Seyyar; Halil Goksel Guzel; Banu Ozturk; Ozge Yalıcı; Duygu Ozaskın; Ramazan Cosar; Fatmagul Cıkladılmez; Evrican Zin; Aytac Terzi; Tugce Ulaslı; Taha Koray Sahın; Denız Can Guven; Gamze Serın; Merve Bıyıklı Alemdar; Bilgin Demir; Ali Kalem; Pervin Can; Kazım Uygun; Elif Sahin; Teoman Sakalar; Ali Kaan Guren; Gokhan Ozturk; Enes Yesılbas; Tugce Kubra Gunes; Burcu Belen; Muzaffer Ugraklı; Kursat Dıslı; Ahmet Oruc; Melek Karakurt Eryılmaz; Ismet Culcuoglu; Mustafa Ersoy; Bahadır Koylu; Fatih Selcukbiricik; Oguzhan Yıldız; Mehmet Emın Yılmaz; Saadettin Kılıckap; Ertugrul Bayram; Caner Acar; Gokhan Sahin; Haydar Cagatay Yuksel; Mustafa Murat Mıdık; Pınar Gursoy; Erdem Goker
err分享
err收藏
Prognostic Value of Systemic Inflammatory Markers in Locally Advanced or Metastatic Melanoma: A Real-World Analysis
errCancers
IF4.4
err2026-01-28
err0
errOAAI
errBurçin Çakan Demirel; Semra Taş; Taliha Güçlü Kantar; Melek Özdemir; Tolga Doğan; Canan Karan; Burcu Yapar Taşköylü; Atike Gökçen Demiray; Serkan Değirmencioğlu; Ahmet Bilici; Gamze Gököz Doğu; Arzu Yaren
err分享
err收藏
Real-World Survival Outcomes Following Metastasectomy in RAS Wild-Type mCRC: Insights from a Multicentre National Cohort Study
errJournal of Clinical Medicine
IF2.9
err2026-01-26
err0
errOAAI
errİlker Nihat Ökten; Tuba Baydaş; Mahmut Emre Yıldırım; Cemil Bilir; Şuayib Yalçın; Erdem Çubukçu; Eda Tanrıkulu Şimşek; Çağatay Aslan; Faysal Dane; Sinemis Çelik; Ahmet Bilici; Mehmet Ali Nahit Şendur; Bala Başak Öven; Abdurrahman Işıkdoğan; Hacı Mehmet Türk; Mustafa Karaca; Bülent Karabulut; Melike Özçelik; Mahmut Gümüş; Umut Kefeli; Nuri Karadurmuş
err分享
err收藏
Durvalumab-Based First-Line Chemoimmunotherapy in Advanced Biliary Tract Cancer: Real-World Outcomes and Prognostic Factors-A Turkish Oncology Group Study
errCANCERS
IF4.4
err2025-12-29
err0
errOAAI
errEfil, Safa Can; Kus, Fatih; Koylu, Bahadir; Durukan, Bekir Mert; Bayram, Selami; Guzel, Halil Goksel; Ozturk, Banu; Muglu, Harun; Bilici, Ahmet; Kose, Fatih; Alan, Ozkan; Karapelit Agitoglu, Eda; Guner, Gurkan; Besen, Ali Ayberk; Helvaci, Kaan; Araz, Murat; Kacan, Turgut; Arslan, Cagatay; Unal, Ahmet; Eniseler, Emine Bihter; Biter, Sedat; Ekinci, Ferhat; Aslan, Ferit; Unek, Ilkay Tugba; Tas, Semra; Acar, Omer; Ates, Ozturk; Sakalar, Teoman; Akbas, Sinem; Karakas, Hilal; Akinci, Muhammed Bulent; Yalcin, Bulent; Yalcin, Suayip; Sendur, Mehmet Ali Nahit
err分享
err收藏
Real-World Outcomes of Treatment Approaches and the Impact of Systemic Inflammation Markers on Survival in Patients with Locally Advanced and Metastatic Laryngeal Cancer局部晚期和转移性喉癌患者治疗方案的疗效及系统性炎症标志物对生存的影响
errJournal of Clinical Medicine 2025, Vol. 14, Page 8924
IF2.9
err2025-12-18
err0
errOAAI
errBurçin Çakan Demirel; Semra Taş; Taliha Güçlü Kantar; Melek Özdemir; Tolga Doğan; Canan Karan; Burcu Yapar Taşköylü; Atike Gökçen Demiray; Serkan Değirmencioğlu; Ahmet Bilici; Gamze Gököz Doğu; Arzu Yaren
err分享
err收藏
Impact of oral nutritional support adherence on muscle strength, body composition, and general health status in gastrointestinal cancer patients: ONMUS study口服营养支持依从性对胃肠道癌患者肌肉力量、身体成分及整体健康状况的影响：ONMUS研究
errNutrition
IF3
err2025-12-01
err1
PREAI
errOzveren, Ahmet; Cil, Timucin; Bicakli, Derya Hopanci; Gultekin, Gamze; Dogan, Dilek; Zengin, Canan; Bilici, Ahmet; Sabir, Songul; Ercelep, Ozlem; Eksi, Feyzanur; Selcukbiricik, Fatih; Yilmaz, Meltem; Ergene, Gozde; Tatli, Ali Murat; Aksoy, Feray Karsli; Uysal, Ozen; Dizdar, Omer; Yildirim, Hasan Cagri; Ozmen, Nesrin; Ozturk, Seniz; Sanli, Ulus Ali; Karabulut, Bulent
err分享
err收藏
Long-Term Oncological Outcomes for Locally Advanced Rectal Cancer Patients with Pathological Complete Response After Neoadjuvant Chemoradiotherapy: A Turkish Oncology Group Study局部晚期直肠癌患者新辅助化放疗后达到病理完全缓解的长期肿瘤学结局：土耳其肿瘤学组研究
errCANCER INVESTIGATION
IF1.9
err2025-12-01
err0
PREAI
errUysal, Mukremin; Saglam, Sezer; Beypinar, Ismail; Saglam, Esra Kaytan; Mammadov, Elkhan; Ocak, Birol; Aybi, Ozge; Arikan, Rukiye; Ergen, Sefika Arzu; Gursoy, Pinar; Sakin, Abdullah; Kaya, Vildan; Ozden, Ercan; Eren, Tulay; Demiray, Atike Gokcen; Oyman, Abdilkerim; Tatli, Ali Murat; Turk, Haci Mehmet; Gulmez, Ahmet; Demir, Atakan; Alan, Ozkan; Sakalar, Teoman; Sen, Erdem; Ucar, Gokhan; Kilickap, Saadettin; Bilici, Ahmet; Oksuz, Didem Colpan; Karabulut, Bulent
err分享
err收藏
Efficacy of Immunotherapy Versus Chemotherapy in Advanced Pleural Mesothelioma: A Turkish Oncology Group (TOG) Study(vol61 , 638 , 2025)免疫疗法与化疗在晚期胸膜间皮瘤中的疗效比较：一项土耳其肿瘤学小组（TOG）研究（vol61，638，2025）
errMEDICINA-LITHUANIA
IF2.4
err2025-11-07
err0
errOAAI
errKalkan, Ziya; Ebinc, Senar; Arcagok, Murat; Bilici, Ahmet; Yildiz, Ozcan; Kilickap, Saadettin; Guven, Deniz Can; Tatli, Ali Murat; Sumbul, Ahmet Taner; Mandel, Nil Molinas; Ozturk, Akin; Bardakci, Murat; Karakaya, Serdar; Kaplan, Muhammet Ali
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
A
Anthony Lucci
H 指数: 72 · 论文数: 553
M
Mehmet Birhan Yılmaz
H 指数: 58 · 论文数: 795
B
Bülent Okan Yıldız
H 指数: 51 · 论文数: 260
A
Arda Işık
H 指数: 43 · 论文数: 216
A
Atilla Soran
H 指数: 40 · 论文数: 259
查看更多